|
1
|
Malgija B, Kumar NS and Piramanayagam S:
Collective transcriptomic deregulation of hypertrophic and dilated
cardiomyopathy-importance of fibrotic mechanism in heart failure.
Comput Biol Chem. 73:85–94. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prinz C, Farr M, Laser KT, Esdorn H, Piper
C, Horstkotte D and Faber L: Determining the role of fibrosis in
hypertrophic cardiomyopathy. Expert Rev Cardiovasc Ther.
11:495–504. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khalil H, Kanisicak O, Prasad V, Correll
RN, Fu X, Schips T, Vagnozzi RJ, Liu R, Huynh T, Lee SJ, et al:
Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac
fibrosis. J Clin Invest. 127:3770–3783. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schafer S, Viswanathan S, Widjaja AA, Lim
WW, Moreno-Moral A, DeLaughter DM, Ng B, Patone G, Chow K, Khin E,
et al: IL-11 is a crucial determinant of cardiovascular fibrosis.
Nature. 552:110–115. 2017.PubMed/NCBI
|
|
5
|
Yu J, Fang Q and Meng S: Knockdown of long
noncoding RNA ENST457720 inhibits proliferation of non-small cell
lung cancer cells in vitro and in vivo. Oncol Res. 1–Mar;2018.(Epub
ahead of print). View Article : Google Scholar
|
|
6
|
Lan T, Chang L, Wu L and Yuan Y:
Downregulation of ZEB2-AS1 decreased tumor growth and metastasis in
hepatocellular carcinoma. Mol Med Rep. 14:4606–4612. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sas-Chen A, Aure MR, Leibovich L, Carvalho
S, Enuka Y, Körner C, Polycarpou-Schwarz M, Lavi S, Nevo N,
Kuznetsov Y, et al: LIMT is a novel metastasis inhibiting lncRNA
suppressed by EGF and downregulated in aggressive breast cancer.
EMBO Mol Med. 8:1052–1064. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhuo C, Jiang R, Lin X and Shao M: LncRNA
H19 inhibits autophagy by epigenetically silencing of DIRAS3 in
diabetic cardiomyopathy. Oncotarget. 8:1429–1437. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang X, Sehgal L, Jain N, Khashab T,
Mathur R and Samaniego F: LncRNA MALAT1 promotes development of
mantle cell lymphoma by associating with EZH2. J Transl Med.
14:3462016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang X and Zhang F: Long noncoding RNA: A
new contributor and potential therapeutic target in fibrosis.
Epigenomics. 9:1233–1241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Zhang YY, Li TT, Wang J, Jiang Y,
Zhao Y, Jin XX, Xue GL, Yang Y, Zhang XF, et al: Ablation of
interleukin-17 alleviated cardiac interstitial fibrosis and
improved cardiac function via inhibiting long non-coding
RNA-AK081284 in diabetic mice. J Mol Cell Cardiol. 115:64–72. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leisegang MS: LET's sponge: How the lncRNA
PFL promotes cardiac fibrosis. Theranostics. 8:874–877. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu W, Peng W, Jiang H, Sha H and Li J:
LncRNA HOXA11-AS promotes proliferation and invasion by targeting
miR-124 in human non-small cell lung cancer cells. Tumour Biol.
39:10104283177214402017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu J, Hong JF, Kang J, Liao LH and Li CD:
Promotion of LncRNA HOXA11-AS on the proliferation of
hepatocellular carcinoma by regulating the expression of LATS1. Eur
Rev Med Pharmacol Sci. 21:3402–3411. 2017.PubMed/NCBI
|
|
15
|
Blom JN, Lu X, Arnold P and Feng Q:
Myocardial infarction in neonatal mice, a model of cardiac
regeneration. J Vis Exp. 24–May;2016.(doi: 10.3791/54100).
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Parameswaran S, Santhakumar R, Vidyasekar
P and Verma RS: Enrichment of cardiomyocytes in primary cultures of
murine neonatal hearts. Methods Mol Biol. 1299:17–25. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ackers-Johnson M, Li PY, Holmes AP,
O'Brien SM, Pavlovic D and Foo RS: A simplified, langendorff-free
method for concomitant isolation of viable cardiac myocytes and
nonmyocytes from the adult mouse heart. Circ Res. 119:909–920.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Souders CA, Bowers SL and Baudino TA:
Cardiac fibroblast: The renaissance cell. Circ Res. 105:1164–1176.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moore-Morris T, Guimarães-Camboa N, Yutzey
KE, Pucéat M and Evans SM: Cardiac fibroblasts: From development to
heart failure. J Mol Med (Berl). 93:823–830. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wrana JL, Attisano L, Cárcamo J, Zentella
A, Doody J, Laiho M, Wang XF and Massagué J: TGF beta signals
through a heteromeric protein kinase receptor complex. Cell.
71:1003–1014. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Massagué J: TGFbeta in cancer. Cell.
134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moustakas A: Smad signalling network. J
Cell Sci. 115:3355–3356. 2002.PubMed/NCBI
|
|
24
|
Chen E, Cen Y, Lu D, Luo W and Jiang H:
IL-22 inactivates hepatic stellate cells via downregulation of the
TGF-β1/Notch signaling pathway. Mol Med Rep. 17:5449–5453.
2018.PubMed/NCBI
|
|
25
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dela Cruz CS, Tanoue LT and Matthay RA:
Lung cancer: Epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
